Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease

scientific article

Development of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CYTO.2006.10.006
P698PubMed publication ID17166734

P2093author name stringQin Wang
Lei Chen
Hongya Wu
Xuefeng Wang
Fang Xie
Yan Ge
Xueguang Zhang
Yongjing Chen
Qiuxia Qu
P2860cites workCross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cellsQ24317763
OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cellsQ28188488
A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitorQ33864621
The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune responseQ36365985
The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cellsQ36366597
Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40taxQ36958543
Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibilityQ45306054
Serum levels of CD137 ligand and CD178 are prognostic factors for progression of myelodysplastic syndromeQ47722948
Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritisQ47923806
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.Q52962713
Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stageQ68468469
Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritisQ73166180
Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cellsQ73400875
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiologyQ73592917
Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus seraQ77738623
Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosisQ77768132
Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCsQ80888591
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectTNF superfamily member 4Q21124644
Graves' diseaseQ50357588
P304page(s)23-8
P577publication date2006-10-01
P1433published inCytokineQ15745296
P1476titleDevelopment of a sandwich ELISA for evaluating soluble OX40L (CD252) in human sera of different ages or with Graves' disease
P478volume36

Reverse relations

cites work (P2860)
Q37177498Enforced covalent trimerisation of soluble feline CD134 (OX40)-ligand generates a functional antagonist of feline immunodeficiency virus
Q38555213OX40, OX40L and Autoimmunity: a Comprehensive Review.
Q34991508Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction
Q53890551Soluble B7-H2 as a novel marker in early evaluation of the severity of acute pancreatitis.
Q34504787Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis

Search more.